Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer

H G van der Poel1

  • 1Department Urology, Netherlands Cancer Institute, Amsterdam. h.vd.poel@nki.nl

European Urology
|November 1, 2005
PubMed
Abstract

Insights

Androgen receptor (AR) overexpression in hormone refractory prostate cancer (HRPC) cells helps them overcome growth inhibition from transforming growth factor beta 1 (TGFbeta1). This explains how AR supports HRPC growth, even without DHT.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Androgen receptor (AR) and transforming growth factor beta 1 (TGFbeta1) signaling are often overexpressed in hormone refractory prostate cancer (HRPC).
  • AR is known to modulate TGFbeta1/Smad signaling pathways.

Purpose of the Study:

  • To evaluate the role of AR in the response to TGFbeta1 in human prostate cancer cell lines.
  • To understand the interplay between AR and TGFbeta1/Smad signaling in HRPC.

Main Methods:

  • Utilized PC3 (AR-negative) and LNCaP-R2 (AR-expressing) prostate cancer cell lines.
  • Performed luciferase reporter assays for AR, TGFbeta1/Smad, and E2F activity.
  • Assessed cell growth, apoptosis, and c-Myc expression following treatment with dihydrotestosterone (DHT) or TGFbeta1.

Main Results:

  • AR and TGFbeta1/Smad signaling mutually inhibited each other transcriptionally.
  • AR expression reduced TGFbeta1/Smad activity and TGFbeta1's growth-inhibitory effects, independent of DHT.
  • TGFbeta1 reduced AR-mediated E2F activity and c-Myc expression, but AR expression prevented TGFbeta1-induced growth inhibition and apoptosis.

Conclusions:

  • AR overexpression enables HRPC cells to resist TGFbeta1-induced growth inhibition, even with elevated TGFbeta1 levels and without DHT.
  • This mechanism provides a rationale for AR's role in promoting HRPC progression.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...